Literature DB >> 28138613

Variations in outcome for advanced gastric cancer between Japanese and Western patients: a subgroup analysis of the RAINBOW trial.

Michael Davidson1, Ian Chau1.   

Abstract

Entities:  

Year:  2016        PMID： 28138613      PMCID： PMC5244696          DOI： 10.21037/tgh.2016.05.06

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  20 in total

Review 1.  Disparities in gastric cancer chemotherapy between the East and West.

Authors:  Atsushi Ohtsu; Shigeaki Yoshida; Nagahiro Saijo
Journal:  J Clin Oncol       Date:  2006-05-10       Impact factor: 44.544

Review 2.  Overall survival as the outcome for randomized clinical trials with effective subsequent therapies.

Authors:  Edward L Korn; Boris Freidlin; Jeffrey S Abrams
Journal:  J Clin Oncol       Date:  2011-05-09       Impact factor: 44.544

3.  Surgical treatment of gastric cancer detected by mass screening.

Authors:  K Hanazaki; H Sodeyama; M Wakabayashi; M Miyazawa; S Yokoyama; Y Sode; N Kawamura; T Miyazaki; M Ohtsuka
Journal:  Hepatogastroenterology       Date:  1997 Jul-Aug

4.  Trends in mortality from major cancers in the European Union, including acceding countries, in 2004.

Authors:  Fabio Levi; Franca Lucchini; Eva Negri; Carlo La Vecchia
Journal:  Cancer       Date:  2004-12-15       Impact factor: 6.860

5.  Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trial.

Authors:  Shuichi Hironaka; Shinya Ueda; Hirofumi Yasui; Tomohiro Nishina; Masahiro Tsuda; Takehiko Tsumura; Naotoshi Sugimoto; Hideki Shimodaira; Shinya Tokunaga; Toshikazu Moriwaki; Taito Esaki; Michitaka Nagase; Kazumasa Fujitani; Kensei Yamaguchi; Takashi Ura; Yasuo Hamamoto; Satoshi Morita; Isamu Okamoto; Narikazu Boku; Ichinosuke Hyodo
Journal:  J Clin Oncol       Date:  2013-11-04       Impact factor: 44.544

6.  Precancerous gastric conditions in high Helicobacter pylori prevalence areas: comparison between Eastern European (Lithuanian, Latvian) and Asian (Taiwanese) patients.

Authors:  Laimas Jonaitis; Audrius Ivanauskas; Dainius Janciauskas; Konrads Funka; Agnese Sudraba; Ivars Tolmanis; Alvils Krams; Dans Stirna; Aigars Vanags; Limas Kupcinskas; Marcis Leja; Jaw-Town Lin
Journal:  Medicina (Kaunas)       Date:  2007       Impact factor: 2.430

7.  Correlation between overall survival and other endpoints in clinical trials of second-line chemotherapy for patients with advanced gastric cancer.

Authors:  Kohei Shitara; Keitaro Matsuo; Kei Muro; Toshihiko Doi; Atsushi Ohtsu
Journal:  Gastric Cancer       Date:  2013-06-05       Impact factor: 7.370

8.  Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.

Authors:  Hansjochen Wilke; Kei Muro; Eric Van Cutsem; Sang-Cheul Oh; György Bodoky; Yasuhiro Shimada; Shuichi Hironaka; Naotoshi Sugimoto; Oleg Lipatov; Tae-You Kim; David Cunningham; Philippe Rougier; Yoshito Komatsu; Jaffer Ajani; Michael Emig; Roberto Carlesi; David Ferry; Kumari Chandrawansa; Jonathan D Schwartz; Atsushi Ohtsu
Journal:  Lancet Oncol       Date:  2014-09-17       Impact factor: 41.316

9.  Neutropenia as a prognostic factor in advanced gastric cancer patients undergoing second-line chemotherapy with weekly paclitaxel.

Authors:  K Shitara; K Matsuo; D Takahari; T Yokota; T Shibata; T Ura; S Ito; A Sawaki; M Tajika; H Kawai; K Muro
Journal:  Ann Oncol       Date:  2010-05-21       Impact factor: 32.976

10.  Comprehensive molecular characterization of gastric adenocarcinoma.

Authors: 
Journal:  Nature       Date:  2014-07-23       Impact factor: 49.962
View more
  1 in total

1.  Asian Americans have better outcomes of non-metastatic gastric cancer compared to other United States racial groups: A secondary analysis from a randomized study.

Authors:  Omar Abdel-Rahman
Journal:  World J Gastrointest Oncol       Date:  2019-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.